CardioFocusPublished in the *Journal of Interventional Cardiac Electrophysiology* onHeartLight X3Latest Research Data.Data Show Laser Ablation BalloonHeartLight X3During pulmonary vein isolation, a high level ofSurvival Rate of SVT (Supraventricular Tachyarrhythmia)。This study enrolled 110 patients with atrial fibrillation (80% with paroxysmal atrial fibrillation, aged 62±13 years; 20% with persistent atrial fibrillation, aged 65±11 years), including 37 female patients (33.6%).More than half of the patients had atrial fibrillation for over 1 year, with an average left atrial size of 43±4.3mm (42±3.9mm for paroxysmal atrial fibrillation and 45±4.5mm for persistent atrial fibrillation).- All ablation procedures achieved pulmonary vein isolation using the RAPID mode. By combining the RAPID mode with point-by-point laser ablation, 91.1% (380/417) of the veins were isolated during the first circumferential lesion application without the need for additional touch-up.
- In the initial surgery, 100% pulmonary vein isolation;
The average operation time was 77.0±22.7 minutes, with a left atrial dwell time of 61.9±22.0 minutes. The total laser irradiation duration for each vein was 5.1±2.3 minutes.
At 1 year post-operation, the SVT-free survival rate was 93.7% for patients with paroxysmal atrial fibrillation and 81.1% for those with persistent atrial fibrillation.
HeartLightIn the era of thermal ablation, it is a revolutionary product that caused quite a stir when it hit the market, comparable to Medtronic's cryoablation technology.Arctic Front Advance is equally anticipated, but unfortunately, it is not available.CardioFocusWithout Medtronic's substantial capital and market resources, the product has not been widely promoted in Europe and the United States.But it also faces the same problems as traditional thermal ablation.For example, pulmonary vein stenosis, atrial-esophageal fistula, etc. DespiteHeartLight X3Relatively safer, but still unable to avoid these serious complications.
With the arrival of the PFA era,HeartLight X3The market will also be greatly impacted. PFA, with itsFocusUltra-high safety and non-inferior effectiveness to thermal ablation, will basically dominate the atrial fibrillation market in the future. ForCardioFocusalso needs change, therefore inHeartLight X3Based on the introduction of HeartLight PFA, combining PFA technology andHeartLight X3The integration of balloon catheter technology has achieved a technological leap. MeanwhileCardioFocusAlso acquiredGalvanize TherapeuticsThe electrophysiology technology department has acquired the advanced electric pulse energy platform, CENTAURI PEF.CardioFocusThe road to PFA has become smoother.
HeartLight X3YesCardioFocusThe latest generation based on endoscopyLaser Ablation Balloon Catheter.
HeartLight X3Three major advantages over traditional thermal ablation:HeartLight X3The balloon is an ultra-compliant Excalibur balloon with a larger size, capable of closely conforming to different anatomical structures.Pulmonary Vein, Achieving Unified Standards.
HeartLight X3It is the only atrial fibrillation ablation catheter with an integrated imaging system, featuring a built-in endoscope.Enables doctors to directly observe the patient's heart.
Through visualization, doctors can intuitively see whether the balloon is effectively adhering to the pulmonary vein, enabling precise energy delivery and thus creating a customized and long-lasting ablation. This reduces reliance on 3D mapping and X-rays, minimizing radiation exposure for both doctors and patients.HeartLight X3Similar to the previous HeartLight, it also uses laser for focusing and precise ablation. Like radiofrequency ablation, the laser energy range is also adjustable (from 5.5W to 15W) to accommodate different pulmonary vein anatomies and provide optimal energy delivery.HeartLight X3The biggest difference from the previous HeartLight is the introduction of the new RAPID mode. The new RAPID mode enables high-power, short-duration doses for precise and continuous energy delivery.HeartLight X3Continuous ablation or point-by-point ablation can be performed to achieve customized ablation.
HeartLight X3 Demonstration
CardioFocusIs a medical device innovator and manufacturer dedicated to advancing ablation treatments for the most common arrhythmias, such as atrial fibrillation (AFib).HeartLightIt is a revolutionary catheter ablation technology characterized by a super-compliant balloon, direct visualization, and titratable laser energy, representing a new standard for AFib ablation.
